Masimo is a medical technology company that develops, manufactures, and markets a variety of noninvasive monitoring technologies and hospital automation solutions. Co.'s main business is Measure-through Motion and Low Perfusion™ pulse oximetry. Co.'s products offerings also include noninvasive monitoring of blood constituents with an optical signature, optical oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring, exhaled gas monitoring, nasal high flow ventilation, minimally invasive neuromodulation technology for pain and addiction reduction, hospital automation™ and connectivity solutions and home wellness and monitoring. We show 59 historical shares outstanding datapoints in our coverage of MASI's shares outstanding history.
Understanding the changing numbers of MASI shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like MASI versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching MASI by allowing them to research MASI shares outstanding history
as well as any other stock in our coverage universe. |
Free MASI Email Alerts:
Video: Shares Outstanding Importance
